Thromb Haemost 1998; 80(02): 310-315
DOI: 10.1055/s-0037-1615193
Rapid Communication
Schattauer GmbH

Characteristics of the Interaction between Thrombin Exosite1 and the Sequence 269-297 of Platelet Glycoprotein Ibα[*]

Marie-Christine Bouton
1   Laboratoire de Recherche sur l‘Hémostase et la Thrombose, Faculté de Médecine Xavier Bichat, Paris, France
,
Christophe Thurieau
2   Laboratoires de Recherche Servier, Suresnes, France
,
Marie-Claude Guillin
1   Laboratoire de Recherche sur l‘Hémostase et la Thrombose, Faculté de Médecine Xavier Bichat, Paris, France
,
Martine Jandrot-Perrus
1   Laboratoire de Recherche sur l‘Hémostase et la Thrombose, Faculté de Médecine Xavier Bichat, Paris, France
› Author Affiliations
Further Information

Publication History

Received 14 October 1997

Accepted after resubmission 09 April 1998

Publication Date:
27 December 2017 (online)

Summary

The interaction between GPIb and thrombin promotes platelet activation elicited via the hydrolysis of the thrombin receptor and involves structures located on the segment 238-290 within the N-terminal domain of GPIbα and the positively charged exosite 1 on thrombin. We have investigated the ability of peptides derived from the 269-287 sequence of GPIbα to interact with thrombin. Three peptides were synthesized, including Ibα 269-287 and two scrambled peptides R1 and R2 which are comparable to Ibα 269-287 with regards to their content and distribution of anionic residues. However, R2 differs from both Ibα 269-287 and R1 by the shifting of one proline from a central position to the N-terminus. By chemical cross-linking, we observed the formation of a complex between 125I-Ibα 269-287 and α-thrombin that was inhibited by hirudin, the C-terminal peptide of hirudin, sodium pyrophosphate but not by heparin. The complex did not form when γ-thrombin was substituted for α-thrombin. Ibα 269-287 produced only slight changes in thrombin amidolytic activity and inhibited thrombin binding to fibrin. R1 and R2 also formed complexes with α-thrombin, modified slightly its catalytic activity and inhibited its binding to fibrin. Peptides Ibα 269-287 and R1 inhibited platelet aggregation and secretion induced by low thrombin concentrations whereas R2 was without effect. Our results indicate that Ibα 269-287 interacts with thrombin exosite 1 via mainly electrostatic interactions, which explains why the scrambled peptides also interact with exosite 1. Nevertheless, the lack of effect of R2 on thrombin-induced platelet activation suggests that proline 280 is important for thrombin interaction with GPIb.

* This work was supported by grants from the European Community (Biomed 2, Contract BMH4-CT96-0937), the MENESR (ACC-SV9) and Université Paris 7. Preliminary accounts of this work were presented at the XVIth Congress of the International Society on Thrombosis and Haemostasis, June, 1997, Florence, Italy and published in an abstract form (Bouton MC, Thurieau C, Guillin MC, Jandrot-Perrus M, Thromb Haemost 1997, Suppl, 604a)


 
  • References

  • 1 Lopez JA. The platelet glycoprotein Ib-IX complex. Blood Coag Fibrinol 1994; 5: 97-119.
  • 2 Vu TKH, Hung DT, Wheaton VI, Coughlin SR. Molecular cloning of a functionnal thrombin receptor reveals a novel proteolytic mechanism of receptor activation. Cell 1991; 64: 1057-68.
  • 3 Jandrot-Perrus M, Clemetson KJ, Huisse MG, Guillin MC. Thrombin interaction with platelet glycoprotein Ib: effect of glycocalicin on thrombin specificity. Blood 1992; 80: 2781-6.
  • 4 De Marco L, Mazzucato M, Masotti A, Fenton JW, Ruggeri ZM. Function of glycoprotein Ibα in platelet activation induced by α-thrombin. J Biol Chem 1991; 266: 23776-83.
  • 5 Jamieson GA, Okumura T. Reduced thrombin binding and aggregation in Bernard-Soulier platelets. J Clin Invest 1978; 61: 861-4.
  • 6 Mc Gowan EB, Detwiler TC. Modified platelet responses to thrombin. J Biol Chem 1986; 261: 739-46.
  • 7 Bouton MC, Jandrot-Perrus M, Moog S, Cazenave JP, Guillin MC, Lanza F. Thrombin interaction with a recombinant N-terminal extracellular domain of the thrombin receptor in an acellular domain. Biochem J 1995; 305: 635-41.
  • 8 Greco NJ, Tandon NN, Jones GD, Kornhauser R, Jackson B, Yamamoto N, Tanoue K, Jamieson GA. Contributions of glycoprotein Ib and the seven transmembrane domain receptor to increases in platelet cytoplasmic [Ca2+] induced by α-thrombin. Biochemistry 1996; 35: 906-14.
  • 9 Greco NJ, Jones GD, Tandon NN, Kornhauser R, Jackson B, Jamieson GA. Differentiation of two forms of GPIb functionning as receptors for α-thrombin and von Willebrand factor: Ca2+ responses of proteases treated human platelets activated with α-thrombin and the tethered ligand peptide. Biochemitry 1996; 35: 915-21.
  • 10 Kramer RM, Roberts EF, Hyslop PA, Utterback BG, Hui KY, Jakubowski JA. Differential activation of cytosolic phospholipase A2 (cPLA2) by thrombin and thrombin receptor agonist peptide in human platelets. J Biol Chem. 1995; 270: 14816-23.
  • 11 Jandrot-Perrus M, Huisse MG, Krstenansky JL, Bezeaud A, Guillin MC. Effect of the hirudin carboxy-terminal peptide on the interaction of thrombin with platelets. Thromb Haemost 1991; 66: 300-5.
  • 12 Rydel TJ, Ravichandran KG, Tulinsky A, Bode W, Huber R, Roitsch C, Fenton JW. The structure of a complex of recombinant hirudin and human α-thrombin. Science 1990; 249: 277-80.
  • 13 Vu TKH, Wheaton VI, Hung DT, Charo I, Coughlin SR. Domains specifying thrombin-receptor interaction. Nature 1991; 353: 674-7.
  • 14 Jandrot-Perrus M, Huisse MG, Ternisien C, Bezeaud A, Guillin MC. Thrombin binding to platelet membrane glycoprotein Ib. Sem Thromb Haemost 1992; 18: 261-6.
  • 15 De Marco L, Mazzucato M, Masotti A, Ruggeri ZM. Localization and characterization of an α-thrombin binding site on glycoprotein Ibα. J Biol Chem. 1994; 269: 6478-84.
  • 16 Gralnick HR, Williams S, Mc Keown LP, Hansmann K, Fenton JW, Krutzsch H. High-affinity α-thrombin binding to platelet glycoprotein Ibα. identification of two binding domains. Proc Natl Acad Sci USA 1994; 91: 6334-8.
  • 17 Trospha A, Kiser JS, Chaiken IM. Making sense from antisense: a review of experimental data and developing ideas on sense-antisense peptide recognition. J Mol. Recognition 1992; 5: 43-54.
  • 18 Baranyi L, Campbell W, Ohshima K, Fujimoto S, Boros M, Okada H. The antisense homology box: a new motif within proteins that encodes biologically active peptides. Nature Medecine 1995; 9: 894-901.
  • 19 Steiner B, Trzeciak A, Pfenninger G, Kouns WC. Peptides derived from a sequence within β3 integrin bind to platelet α2β3 (GPIIb-IIIa) and inhibit ligand binding. J Biol Chem 1993; 268: 6870-3.
  • 20 Bezeaud A, Denninger MH, Guillin MC. Interaction of human α-thrombin and β-thrombin with antithrombin III, protein C and thrombomodulin. Eur J Biochem 1985; 153: 491-6.
  • 21 Le Bonniec BF, Myles T, Johnson T, Knight CG, Taparelli C, Stone SR. Characterisation of the P’2 and P’3 specificities of thrombin using fluorescence-quenched substrates and mapping subsites by mutagenesis. Biochemistry 1996; 35: 7114-22.
  • 22 Jandrot-Perrus M, Didry D, Guillin MC, Nurden AT. Cross-linking of α-and β-thrombin to distinct binding sites on human platelets. Eur J Biochem 1988; 174: 359-67.
  • 23 Skrzypczak-Jankun E, Carperos VE, Ravichandran KG, Tulinsky A, Westbrook M, Maraganore JM. The structure of the hirugen and and the hirulog-1 complexes of α-thrombin. J Mol Biol 1991; 221: 1379-93.
  • 24 Bode W, Turk D, Karshikov A. The refined 1.9 A X-ray crystal structure of human α-thrombin: interaction with D-Phe-Pro-Arg chloromethylketone and significance of the Tyr-Pro-Pro Trp insertion fragment. Protein Sci 1992; 1: 426-71.
  • 25 Rydel TJ, Yin M, Padmanabhan KP, Blankenship DT, Cardin AD, Correa PE, Fenton JW, Tulinsky A T. Crystallographic structure of human γ-thrombin. J Biol Chem 1994; 269: 22000-6.
  • 26 Hortin GL, Trimpe BL. Allosteric changes in thrombin’s activity by peptides corresponding to segments of natural inhibitors and substrates. J Biol Chem 1991; 266: 6866-71.
  • 27 Liu LW, Vu TKH, Esmon CT, Coughlin SR. The region of the thrombin receptor ressembling hirudin binds to thrombin and alters enzyme specificity. J Biol Chem 1991; 266: 16977-80.
  • 28 De Candia E, De Cristofaro R, De Marco L, Mazzucato M, Picozzi M, Landolfi R. Thombin interaction with platelet GPIb: role of the heparin binding domain. Thromb Haemost 1997; 77: 735-40.
  • 29 Dong JF, Li CQ, Lopez JA. Tyrosine sulfatation of the glycoprotein Ib-IX complex: identification of sulfated residues and effect on ligand binding. Biochemistry 1994; 33: 13946-53.
  • 30 Hung DT, Vu TKH, Wheaton VI, Ishii K, Coughlin SR. Cloned platelet receptor is necessary for thrombin-induced platelet activation. J Clin Invest 1992; 89: 1350-3.
  • 31 Krstenansky JL, Mao SJT. Antithrombin properties of C-terminus of hirudin using synthetic unsulfated N-α-acetyl-hirudin 45-65. FEBS Lett 1987; 211: 10-6.
  • 32 Katagiri Y, Hayashi Y, Yamamoto K, Tanoue K, Kosaki G, Yamasaki H. Localisation of von Willebrand factor and thrombin interactive domains on human platelet glycoprotein Ib. Thromb Haemost 1990; 63: 122-6.
  • 33 Miller JL, Lyle VA. Mimotope / antimimotope probing of the structural relationships in platelet glycoprotein Ibα. Proc Natl Acad Sci USA 1996; 93: 3565-9.
  • 34 Harmon JT, Jamieson GA. Thrombin binds to a high-affinity ~900,000 dalton site on human platelets. Biochemistry 1985; 24: 58-64.